Efficacy and Safety of Pregabalin in the Treatment of Patients With Painful Diabetic Peripheral Neuropathy and Pain on Walking

Autor: Chunming Li, Lynne Pauer, Michael Tuchman, Cynthia Huffman, Bruce Parsons, Joseph M. Scavone, Claire Burbridge, Brett R. Stacey, Regina Behar, Lorraine Yurkewicz

Publikováno v: The Clinical Journal of Pain. 31:946-958

This randomized, double-blind, placebo-controlled, multicenter, 2-period crossover study (two 6-week treatment periods separated by a 2-week washout period) evaluated the efficacy and safety of pregabalin (150 to 300 mg/d) for treatment of pain and p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c25eea314202e6b39f3a274604b418d2
https://doi.org/10.1097/ajp.0000000000000198

Economic and humanistic burden of post-trauma and post-surgical neuropathic pain among adults in the United States

Autor: Alesia Sadosky, Bruce Parsons, Caroline Schaefer, Michael Tuchman, Brett R. Stacey, Rachael Mann, Edward C Nieshoff, Alan Anschel, Srinivas Nalamachu, S. Daniel

Publikováno v: Journal of Pain Research

Bruce Parsons,1 Caroline Schaefer,2 Rachael Mann,3 Alesia Sadosky,1 Shoshana Daniel,4 Srinivas Nalamachu,5 Brett R Stacey,6 Edward C Nieshoff,7 Michael Tuchman,8 Alan Anschel91Pfizer, Inc, New York, NY, USA; 2Covance Market Access Services, Inc, Gait

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a456cc15af3caef9a61c0dc19202d295
http://europepmc.org/articles/PMC3698142

Bapineuzumab for mild to moderate Alzheimer's disease in two global, randomized, phase 3 trials

Autor: Tom McRae, Gerald Luscan, Prisca Lucas, Kasia Lobello, David Li, Mercè Boada, Achim Gass, Sadao Katayama, Lingfeng Yang, H. Robert Brashear, Lisa Hua, Ronald Black, Michael Tuchman, Kevin Booth, Bruno Vellas, Rik Vandenberghe, Philip Scheltens, Iona Evans, Bradley T. Wyman, Jochen B. Fiebach, Juha O. Rinne, Derek L. G. Hill

Publikováno v: Alzheimer's Research & Therapy
Vandenberghe, R, Rinne, J O, Boada, M, Katayama, S, Scheltens, P, Vellas, B, Tuchman, M, Gass, A, Fiebach, J B, Hill, D, Lobello, K, Li, D, McRae, T, Lucas, P, Evans, I, Booth, K, Luscan, G, Wyman, B T, Hua, L, Yang, L, Brashear, H R, Black, R S & Bapineuzumab 3000 and 3001 Clinical Study Investigators 2016, ' Bapineuzumab for mild to moderate Alzheimer's disease in two global, randomized, phase 3 trials ', Alzheimer's Research & Therapy, vol. 8, no. 1, 18 . https://doi.org/10.1186/s13195-016-0189-7
Alzheimer's Research & Therapy, 8(1):18. BioMed Central

Background Our objective was to evaluate the efficacy (clinical and biomarker) and safety of intravenous bapineuzumab in patients with mild to moderate Alzheimer’s disease (AD). Methods Two of four phase 3, multicenter, randomized, double-blind, pl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84132c233a2e65697604ddfa3a7a1bbc
https://doi.org/10.1186/s13195-016-0189-7

Burden of illness associated with peripheral and central neuropathic pain among adults seeking treatment in the United States: a patient-centered evaluation

Autor: Michael Tuchman, Alan Anschel, Srinivas Nalamachu, Alesia Sadosky, Caroline Schaefer, Bruce Parsons, Rachael Mann, Edward C Nieshoff, S. Daniel, Brett R. Stacey

Publikováno v: Pain Medicine (Malden, Mass.)

Objective The aim of this study was to evaluate patient-reported burden associated with peripheral and central neuropathic pain (NeP) by pain severity and NeP condition. Design Six hundred twenty-four subjects with one of six NeP conditions were recr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8473874ce419412f125052d47377c01c
https://pubmed.ncbi.nlm.nih.gov/25039856

Rizatriptan (MAXALT) for the Acute Treatment of Migraine and Migraine Recurrence. A Placebo-Controlled, Outpatient Study

Autor: Scott A. Reines, Michael Gross, Betty Smith, Michael Tuchman, Gilbert A. Block, Judith Teall, Ernest Willoughby, Neal R. Cutler, Kai Jiang

Publikováno v: Headache: The Journal of Head and Face Pain. 38:281-287

Rizatriptan is a novel 5-HT1B/1D agonist which is rapidly absorbed after oral administration. The efficacy and tolerability of oral rizatriptan (5 mg and 10 mg) were examined in this multicenter, double-blind, outpatient study of 1473 migraineurs whi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a93ae1553b3fdd5ea8037c1602e0cb61
https://doi.org/10.1046/j.1526-4610.1998.3804281.x